![Jean-Marc Bellemin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Marc Bellemin
Amministratore Delegato presso
CHIESI Farmaceutici SpA
Patrimonio netto: 251 801 $ in data 30/06/2026
Profilo
Jean-Marc Bellemin ricopre la posizione di CFO & Principal Accounting Officer di Iovance Biotherapeutics, Inc. In passato è stato Chief Financial Officer & Executive Vice President di Gritstone Oncology, Inc. e Senior Vice President-Business Solutions di Actelion Pharmaceuticals US, Inc. Il sig. Bellemin ha conseguito una laurea presso l'Universit Paris Dauphine-PSL, una laurea presso l'Universit Paris II Panthon Assas e un MBA presso la ESSEC Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 02/06/2025 | 60.529 ( 0,01% ) | 251 801 $ | 30/06/2026 |
Posizioni attive di Jean-Marc Bellemin
| Società | Posizione | Inizio |
|---|---|---|
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Amministratore Delegato | 15/05/2026 |
Precedenti posizioni note di Jean-Marc Bellemin
| Società | Posizione | Fine |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Direttore Finanziario/CFO | 30/06/2025 |
| GRITSTONE BIO, INC. | Direttore Finanziario/CFO | 11/12/2020 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Corporate Officer/Principal | 01/12/2017 |
Formazione di Jean-Marc Bellemin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
20
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Health Technology |
Université Paris Dauphine-PSL
 Université Paris Dauphine-PSL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESSEC Business School
 ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris II Panthéon Assas
 Université Paris II Panthéon Assas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
